Real-world outcomes of elexacaftor/tezacaftor/ivacaftor in a cohort of children and adolescents with cystic fibrosis in Brazil
Objective: To describe real-world clinical outcomes associated with elexacaftor/ tezacaftor/ivacaftor (ETI) in people with cystic fibrosis (pwCF) followed at a pediatric referral center in Brazil. Methods: This was a retrospective analysis nested within a prospective cohort study conducted between February of 2023 an...